Baby Iron Bioavailability Study

Iron Bioavailability Clinical Trial

Official title:
Iron Bioavailability From Fortified Cereal in Malawian Infants

Status Completed

Clinical Trial Summary

The overall objective of this trial is to investigate the iron bioavailability from new infant cereals in Malawian infants.

Clinical Trial Description

In 30 infants aged 6 to 14 months old, the investigator will administer in random order over 2 phases separated by 14 days, 5 infant cereals containing either ferrous fumarate (4 meals) or ferrous bisglycinate (1 meal) intrinsically labeled with stable isotopes. The investigator will collect one blood sample at baseline and another sample at the end of each phase, thus 3 samples total. In these samples, fractional iron absorption and markers of iron and inflammation status will be measured . In addition, infant and child acceptability of one of the infant cereals will be assessed by using a questionnaire. ;

Study Design

Related Conditions & MeSH terms

Iron Bioavailability

Clinical Trial Details

NCT number	NCT03754543
Study type	Interventional
Source	Nestlé
Contact
Status	Completed
Phase	N/A
Start date	January 31, 2019
Completion date	June 12, 2019

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05061290` - Iron Bioavailability From Cereal-based Foods	N/A
Completed	`NCT03156725` - Assessment of Iron Absorption From Aspergillus Oryzae	N/A
Completed	`NCT02370940` - Regular Consumption of High Phytate Reduces Inhibitory Effect of Phytate on Iron Absorption	N/A
Completed	`NCT02462798` - Does Sourdough Fermentation Improve Iron Uptake From Whole Grain Rye Bread?	N/A
Completed	`NCT02993835` - Iron Bioavailability From Fortified Food	N/A